ACTIVE

PHARMANEMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

35,7 k €

-4.3% YoY

Gross margin

114,5 k €

+15.5% YoY

Equity

357,6 k €

+7.7% YoY

What does PHARMANEMA do?

PHARMANEMA is a Private limited company incorporated in 2002. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Leuven.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0479.052.415

Incorporation

23/12/2002

Legal form

Private limited company

Registered office

Albert Woutersstraat 9
3012 Leuven · FlandreSee on map

Contributed capital

25 000,00 €

Latest accounts

31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	114,5 k €	+15.5%	99,1 k €	-6.4%	105,9 k €	+30.3%	81,3 k €	+0.7%	80,7 k €	+42.3%	56,7 k €	-27.5%	78,2 k €	+71.1%	45,7 k €	+1.5%	45,1 k €	-37.6%	72,2 k €	+39.2%	51,9 k €	-27.1%	71,1 k €	-29.4%	100,6 k €	+14.3%	88 k €	+13.8%	77,4 k €	+1.9%	75,9 k €	-17.7%	92,2 k €	-4.7%	96,8 k €	+112%	45,7 k €	-66.3%	135,6 k €
EBITDA	112,1 k €	+15.8%	96,8 k €	-6.6%	103,7 k €	+31.1%	79 k €	+0.5%	78,7 k €	+43.8%	54,7 k €	-28.5%	76,5 k €	+73.8%	44 k €	+1.5%	43,4 k €	-38.5%	70,5 k €	+40.8%	50,1 k €	-27.1%	68,7 k €	-30.1%	98,3 k €	+14.6%	85,7 k €	+14.2%	75 k €	+1.8%	73,7 k €	-18.1%	90 k €	-5.4%	95,1 k €	+112%	44,8 k €	-45.6%	82,4 k €
Operating result	65 k €	+4.9%	61,9 k €	-30.0%	88,5 k €	+37.6%	64,3 k €	-1.1%	65,1 k €	+58.1%	41,1 k €	-33.9%	62,3 k €	+106%	30,3 k €	+86.2%	16,2 k €	-59.7%	40,3 k €	+98.7%	20,3 k €	-48.7%	39,6 k €	-43.8%	70,4 k €	+79.1%	39,3 k €	+40.1%	28,1 k €	+10.1%	25,5 k €	-38.8%	41,7 k €	-10.4%	46,5 k €	+291%	-24,3 k €	-142%	58 k €
Net result	35,7 k €	-4.3%	37,3 k €	-49.2%	73,4 k €	+47.9%	49,6 k €	+9.4%	45,4 k €	+67.5%	27,1 k €	-48.8%	52,9 k €	+144%	21,7 k €	+130%	9,4 k €	-66.2%	27,8 k €	+347%	6,2 k €	-61.8%	16,3 k €	-51.6%	33,7 k €	+163%	12,8 k €	+266%	3,5 k €	+66.4%	2,1 k €	-88.6%	18,4 k €	-23.3%	24 k €	+153%	-45 k €	-251%	29,8 k €
Balance sheet
Equity	357,6 k €	+7.7%	331,9 k €	+9.0%	304,7 k €	+8.3%	281,3 k €	+9.6%	256,6 k €	+11.0%	231,3 k €	+13.3%	204,2 k €	+1.4%	201,3 k €	+0.8%	199,6 k €	+0.7%	198,2 k €	+4.1%	190,4 k €	+3.4%	184,2 k €	+9.7%	167,9 k €	+25.1%	134,3 k €	+10.5%	121,5 k €	+3.0%	118 k €	+1.8%	115,9 k €	+18.9%	97,5 k €	+32.7%	73,5 k €	-38.0%	118,5 k €
Total assets	910 k €	+12.3%	810,5 k €	+9.3%	741,5 k €	+12.6%	658,7 k €	+30.6%	504,3 k €	-19.1%	623,7 k €	+23.3%	505,8 k €	+4.0%	486,2 k €	-4.0%	506,3 k €	-11.8%	573,8 k €	+3.4%	554,8 k €	-3.5%	575,1 k €	-9.5%	635,2 k €	-2.2%	649,3 k €	-7.5%	701,6 k €	-1.0%	708,9 k €	-10.2%	789,1 k €	+2.9%	766,8 k €	+7.4%	713,9 k €	+46.2%	488,2 k €
Cash	95,9 k €	-10.1%	106,7 k €	-61.0%	273,3 k €	+259%	76,1 k €	+94.8%	39,1 k €	-4.5%	40,9 k €	+120%	18,6 k €	-42.2%	32,2 k €	-37.0%	51,2 k €	-21.8%	65,4 k €	+85.4%	35,3 k €	+2.0%	34,6 k €	-43.7%	61,5 k €	-23.2%	80,1 k €	+22.0%	65,7 k €	+7.1%	61,3 k €	-15.6%	72,6 k €	+24.5%	58,3 k €	-54.4%	128 k €	-48.8%	250 k €
Debts	549,2 k €	+16.6%	471 k €	+8.8%	433 k €	+15.8%	374,1 k €	+53.0%	244,6 k €	-37.3%	389,9 k €	+30.4%	299 k €	+5.9%	282,3 k €	-7.9%	306,7 k €	-18.4%	375,6 k €	+3.1%	364,4 k €	-6.8%	390,9 k €	-16.3%	467,3 k €	-9.3%	515 k €	-11.2%	580,2 k €	-1.8%	590,9 k €	-12.2%	673,2 k €	+1.5%	663,1 k €	+4.6%	634,3 k €	+76.1%	360,2 k €
Other
Workforce	–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		1,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

VANHALEWYCK-VAN OOSTERWYCK

Director · 0886.009.876

Represented by Tom Vanhalewyck

Active

Ended mandates

VANHALEWYCK-VAN OOSTERWYCK

Manager · since 01 janvier 2007 · 0886.009.876

Represented by Tom Vanhalewijck

Ended

Ann Van Hellemont

Manager · since 08 janvier 2003 · until 01 janvier 2007

Ended

Marc Van Hellemont

Manager · until 01 janvier 2007

Ended

VANHALEWYCK-VAN OOSTERWYCK

Manager · 0886.009.876

Ended

At this address

Other companies at this address

Company	CBE no.
VANHALEWYCK-VAN OOSTERWYCK● Active	0886.009.876

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	07/07/2026	11/07/2025	05/07/2024	01/06/2023	16/06/2022	18/06/2021
General meeting	12/06/2026	13/06/2025	14/06/2024	26/05/2023	27/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	12/06/2026	07/07/2026	Dutch	PDF
Abridged model	31/12/2024	13/06/2025	11/07/2025	Dutch	PDF
Abridged model	31/12/2023	14/06/2024	05/07/2024	Dutch	PDF
Abridged model	31/12/2022	26/05/2023	01/06/2023	Dutch	PDF
Abridged model	31/12/2021	27/05/2022	16/06/2022	Dutch	PDF
Abridged model	31/12/2020	28/05/2021	18/06/2021	Dutch	PDF
Abridged model	31/12/2019	12/06/2020	07/08/2020	Dutch	PDF
Abridged model	31/12/2018	24/05/2019	21/06/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	08/06/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	08/06/2017	Dutch	PDF
Abridged model	31/12/2015	27/05/2016	27/05/2016	Dutch	PDF
Abridged model	31/12/2014	22/05/2015	05/06/2015	Dutch	PDF
Abridged model	31/12/2013	23/05/2014	27/05/2014	Dutch	PDF
Abridged model	31/12/2012	24/05/2013	28/06/2013	Dutch	PDF
Abridged model	31/12/2011	25/05/2012	12/06/2012	Dutch	PDF
Abridged model	31/12/2010	17/06/2011	20/06/2011	Dutch	PDF
Abridged model	31/12/2009	18/06/2010	13/07/2010	Dutch	PDF
Abridged model	31/12/2008	12/06/2009	07/07/2009	Dutch	PDF
Abridged model	31/12/2007	13/06/2008	08/07/2008	Dutch	PDF
Abridged model	31/12/2006	25/05/2007	13/07/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 8 ended

Active mandates

VANHALEWYCK-VAN OOSTERWYCK

Director · 0886.009.876

Represented by Tom Vanhalewyck

Active

Ended mandates

VANHALEWYCK-VAN OOSTERWYCK

Manager · since 01 janvier 2007 · 0886.009.876

Represented by Tom Vanhalewijck

Ended

Ann Van Hellemont

Manager · since 08 janvier 2003 · until 01 janvier 2007

Ended

Marc Van Hellemont

Manager · until 01 janvier 2007

Ended

VANHALEWYCK-VAN OOSTERWYCK

Manager · 0886.009.876

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates16/03/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/01/2007
ONTSLAGEN - BENOEMINGEN
PDF
Mandates19/05/2005
ONTSLAGEN - BENOEMINGEN
PDF
Mandates30/01/2003
ONTSLAGEN - BENOEMINGEN
PDF
Other02/01/2003
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202535,7 k €↓
2024
Annual accounts 202437,3 k €↓
2023
Annual accounts 202373,4 k €↑
2022
Annual accounts 202249,6 k €↑
2021
Annual accounts 202145,4 k €↑
2020
Annual accounts 202027,1 k €↓
2019
Annual accounts 201952,9 k €↑
2018
Annual accounts 201821,7 k €↑
2017
Annual accounts 20179,4 k €↓
2016
Annual accounts 201627,8 k €↑
2015
Annual accounts 20156,2 k €↓
2014
Annual accounts 201416,3 k €↓
2013
Annual accounts 201333,7 k €↑
2012
Annual accounts 201212,8 k €↑
2011
Annual accounts 20113,5 k €↑
2010
Annual accounts 20102,1 k €↓
2009
Annual accounts 200918,4 k €↓
2008
Annual accounts 200824 k €↑
2007
Annual accounts 2007-45 k €↓
2006
Annual accounts 200629,8 k €
23/12/2002
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMANEMA

Overview

What does PHARMANEMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline